GSK-3β inhibitor 26
GSK-3β inhibitor 26 (Compound D14) is a GSK-3β inhibitor with an IC50 of 18.23 μM. GSK-3β inhibitor 26 can be used in the research of cancer, inflammation and neurodegenerative diseases[1].
Product Specifications
CAS Number
[70169-39-0]
UNSPSC
12352005
Target
GSK-3
Related Pathways
PI3K/Akt/mTOR; Stem Cell/Wnt
Field of Research
Cancer; Inflammation/Immunology; Neurological Disease
Smiles
O=C(C1=C(O)C=CC=C1)N/N=C2C(NC3=C\2C=CC=C3)=O
Molecular Formula
C15H11N3O3
Molecular Weight
281.27
References & Citations
[1]Dou X, et al. Discovery of new GSK-3β inhibitors through structure-based virtual screening. Bioorg Med Chem Lett. 2018 Jan 15;28 (2) :160-166.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
GSK-3β
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1581270-01 0.1 mg
Research Grade Anti-Human CD123/IL3RA (CSL360)
Sign In for Pricing
View Details 
MBS1581270-03 5x 1 mg
Research Grade Anti-Human CD123/IL3RA (CSL360)
Sign In for Pricing
View Details 66344111 3x 1.0 µg
PRKCA sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)
Sign In for Pricing
View Details MBS635632-01 0.1 mg
UbcH1, Recombinant, Human (Huntingtin-interacting Protein 2, HIP2, HIP-2, LIG, Ubiquitin Carrier Protein, Ubiquitin-conjugating Enzyme E2 K, UBE2K, Ubiquitin-conjugating Enzyme E2-25kD, Ubiquitin-conjugating Enzyme E2(25K), Ubiquitin-conjugating Enzyme E2
Sign In for Pricing
View Details